Tag : Announces

Latest News

Veredus Laboratories announces development of detection kit for Wuhan Coronavirus

Newsemia
Singapore-based Veredus Laboratories, a provider of innovative molecular diagnostic solutions, recently announced the development of VereCoV detection kit, a portable Lab-on-Chip application capable of detecting...
Biology

QCDx Announces Sale of the RareScope to the Carole and Ray Neag Comprehensive Cancer Center at UConn Health for Use in Clinical Research

Newsemia
FARMINGTON, Conn. (PRWEB) January 21, 2020 QCDx , a private biotech company that has developed a breakthrough Circulating Tumor Cell (CTC) liquid biopsy from a...
Biology

Sierra Announces NEW Line of MEMS-Based Thermal Mass Flow Controllers & Flow Meters

Newsemia
MONTEREY, Calif. (PRWEB) January 24, 2020 Sierra Instruments, global leader in mass flow, announces the launch of their RedySmartâ„¢ mass flow meters and controllers ideal...
Biology

Brilliant Announces Partnership with WAVE Electronics to Offer Turnkey Smart Home Packages for Homebuilders and Multifamily Developers/Operators

Newsemia
SAN MATEO, Calif. (PRWEB) January 20, 2020 Brilliant, maker of the award-winning Brilliant Smart Home System, today announced a partnership with WAVE Electronics, the largest...
Latest News

Elanco Animal Health Announces Common Stock and Tangible Equity Unit Offerings Associated with Financing Acquisition of Bayer’s Animal Health Business

Newsemia
GREENFIELD, Ind.–(BUSINESS WIRE)–Elanco Animal Health Incorporated (NYSE: ELAN) today announced it intends to make concurrent public offerings of 19,159,866 shares of its common stock and...
Latest News

Alnylam Announces Preliminary* Fourth Quarter and Full Year 2019 Global Net Product Revenues and Provides Additional Commercial Updates

Newsemia
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced its preliminary* fourth quarter and full year 2019 global net product...
Latest News

Zymeworks Announces Agreement with Pfizer and Initiation of a New Phase 2 Trial Evaluating ZW25 in Combination with Ibrance® (palbociclib)

Newsemia
VANCOUVER, British Columbia–(BUSINESS WIRE)–Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional therapeutics, today announced the initiation of a Phase 2 trial evaluating ZW25...
Biology

Vuja De Sciences Announces the Appointment of Two New Board Members

Newsemia
HOBOKEN, N.J. (PRWEB) January 07, 2020 Vuja De Sciences (“Vuja De�), a biotechnology startup dedicated to developing cancer metastasis treatments that prevent cancer progression and...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy